Omega Therapeutics Inc Revenue Growth Rates (OMGA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Omega Therapeutics Inc   (NASDAQ: OMGA)
 

OMGA's Revenue Growth by Quarter and Year

Omega Therapeutics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OMGA Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September 2.61
2nd Quarter June 2.13
1st Quarter March 2.36
FY 7.10





OMGA Revenue third quarter 2024 Y/Y Growth Comment
Omega Therapeutics Inc achieved in the third quarter 2024, above Company average Revenue surge of 214.7% year on year, to $ 2.61 millions.

Looking into third quarter 2024 results within Biotechnology & Pharmaceuticals industry 11 other companies have achieved higher Revenue growth. While Omega Therapeutics Inc ' s Revenue doubling of 214.7% ranks overall at the positon no. 102 in the third quarter 2024.


OMGA Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - 35.62 % - -
3rd Quarter September 214.7 % 38.33 % - -
2nd Quarter June 180.26 % 58.33 % - -
1st Quarter March 353.85 % 92.59 % - -
FY   - 49.04 % - -

Financial Statements
Omega Therapeutics Inc 's third quarter 2024 Revenue $ 2.61 millions OMGA's Income Statement
Omega Therapeutics Inc 's third quarter 2023 Revenue $ 0.83 millions Quarterly OMGA's Income Statement


OMGA Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - 19.28 % 21.67 % -
3rd Quarter September 22.63 % 9.21 % 25 % -
2nd Quarter June -9.75 % 46.15 % 77.78 % -
1st Quarter March 138.38 % -28.77 % - -
FY (Year on Year)   - 49.04 % - -


Back to OMGA Growth rate Comparisons >> Back to OMGA Growth rate Comparisons >>


Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #12
Healthcare Sector #35
Overall #102

Revenue Y/Y Growth Statistics
High Average Low
357.36 % 139.87 % 34.6 %
(Sep 30 2024)   (Dec 31 2023)
Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #12
Healthcare Sector #35
Overall #102
Revenue Y/Y Growth Statistics
High Average Low
357.36 % 139.87 % 34.6 %
(Sep 30 2024)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Omega Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
138.87 % 32.34 % -29.7 %
(Mar 31 2024)  


OMGA's III. Quarter Q/Q Revenue Comment
Omega Therapeutics Inc achieved in the III. Quarter 2024 below company average Revenue jump of 22.63% quarter on quarter, to $ 2.61 millions.

III. Quarter 2024 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 9.21% in the III. Quarter a year ago.

Within Biotechnology & Pharmaceuticals industry 21 other companies have achieved higher Revenue quarter on quarter growth. While Omega Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 512.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #22
Healthcare Sector #119
Overall #512
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #22
Healthcare Sector #119
Overall #512
Revenue Q/Q Growth Statistics
High Average Low
138.87 % 32.34 % -29.7 %
(Mar 31 2024)  


OMGA's III. Quarter Q/Q Revenue Comment
Omega Therapeutics Inc achieved in the III. Quarter 2024 below company average Revenue jump of 22.63% quarter on quarter, to $ 2.61 millions.

III. Quarter 2024 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 9.21% in the III. Quarter a year ago.

Within Biotechnology & Pharmaceuticals industry 21 other companies have achieved higher Revenue quarter on quarter growth. While Omega Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 512.


Omega Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)
Cumulative Revenue 12 Months Ending $ 8.09 $ 6.31 $ 4.94 $ 3.09 $ 2.84
Y / Y Revenue Growth (TTM) 185 % 142.43 % 112.75 % 49.25 % -
Year on Year Revenue Growth Overall Ranking # 252 # 243 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 28.21 % 27.85 % 59.6 % 8.94 % 9.06 %
Seq. Revenue Growth (TTM) Overall Ranking # 1204 # 944 # 0 # 0 # 1236


Cumulative Revenue growth Comment
With 185% annual Revenue growth, Omega Therapeutics Inc would report a record annual Revenue surge if the fiscal year would end on Sep 30 2024.

In the Healthcare sector 81 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 243 to 252.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 30
Healthcare Sector # 82
Overall # 252

Revenue TTM Y/Y Growth Statistics
High Average Low
185 %
 122.36 %
49.25 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 255
S&P 500 # 1204
Cumulative Revenue growth Comment
With 185% annual Revenue growth, Omega Therapeutics Inc would report a record annual Revenue surge if the fiscal year would end on Sep 30 2024.

In the Healthcare sector 81 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 243 to 252.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 30
Healthcare Sector # 82
Overall # 252

Revenue TTM Y/Y Growth Statistics
High Average Low
185 %
122.36 %
49.25 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 255
S&P 500 # 1204




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OMGA's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Sep 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2024
Earth Science Tech Inc 341.92%$ 341.923 millions
Sage Therapeutics Inc 337.08%$ 337.077 millions
Shattuck Labs Inc 336.88%$ 336.880 millions
Regen Biopharma Inc 260.98%$ 260.983 millions
Generation Bio Co 252.00%$ 252.004 millions
Orgenesis Inc 215.45%$ 215.455 millions
Omega Therapeutics Inc 214.32%$ 214.320 millions
Lineage Cell Therapeutics Inc 203.29%$ 203.291 millions
Arvinas Inc 195.95%$ 195.954 millions
Imagenebio Inc 195.36%$ 195.359 millions
Volitionrx Limited187.22%$ 187.222 millions
Proqr Therapeutics N v 183.16%$ 183.160 millions
Oncternal Therapeutics Inc 175.98%$ 175.978 millions
Zivo Bioscience Inc 166.95%$ 166.949 millions
Scpharmaceuticals Inc 164.12%$ 164.120 millions
Dariohealth Corp 163.49%$ 163.487 millions
Kronos Bio Inc 158.45%$ 158.451 millions
Accelerate Diagnostics Inc 157.99%$ 157.995 millions
Recursion Pharmaceuticals Inc 147.62%$ 147.622 millions
Celularity Inc 145.54%$ 145.536 millions
Armata Pharmaceuticals Inc 142.69%$ 142.694 millions
Rosecliff Acquisition Corp I137.59%$ 137.587 millions
Chimerix Inc 136.36%$ 136.364 millions
Orchestra Biomed Holdings Inc 135.56%$ 135.561 millions
Dianthus Therapeutics Inc 135.06%$ 135.065 millions
Vaxart Inc 134.79%$ 134.793 millions
Absci Corp128.63%$ 128.629 millions
Femasys Inc 127.09%$ 127.085 millions
Sensus Healthcare Inc 126.76%$ 126.757 millions
Blueprint Medicines Corporation126.61%$ 126.610 millions


About Omega Therapeutics Inc Revenue Growth Rates (OMGA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Omega Therapeutics Inc (CIK 1850838).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000950170-24-127008
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Omega Therapeutics Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.